Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (93)

2023

  1. Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  2. Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder

    International journal of molecular sciences, Vol. 24, Núm. 11

  3. Dissecting operant alcohol self-administration using saccharin-fading procedure

    Neuropsychopharmacology Reports, Vol. 43, Núm. 1, pp. 12-22

  4. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  5. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  6. Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders

    Translational Psychiatry, Vol. 13, Núm. 1

2022

  1. Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"

    Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461

  2. Galanin N-terminal fragment (1−15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system

    Biomedicine and Pharmacotherapy, Vol. 153

  3. Gut microbiota and voluntary alcohol consumption

    Translational Psychiatry, Vol. 12, Núm. 1

  4. Niveles plasmáticos de midkina en pacientes con trastorno por uso de cocaína en abstinencia

    Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 273-277

  5. Oleoylethanolamide attenuates the stress-mediated potentiation of rewarding properties of cocaine associated with an increased TLR4 proinflammatory response

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 124

  6. Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex

    Biomedicines, Vol. 10, Núm. 5

  7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

    IJID Regions, Vol. 4, pp. 10-16

  8. Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders

    Brain Sciences, Vol. 12, Núm. 5

  9. Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder

    Biomedicines, Vol. 10, Núm. 5

2021

  1. Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking

    Addiction Biology, Vol. 26, Núm. 3

  2. Alcohol mixed with energy drinks: what about taurine?

    Psychopharmacology, Vol. 238, Núm. 1

  3. Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 108

  4. Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder

    Autism Research, Vol. 14, Núm. 9, pp. 1854-1872

  5. Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder

    Scientific Reports, Vol. 11, Núm. 1